Christine Kampf

Vice President, Regulatory Affairs

Professional Overview

Christine Kampf is an accomplished regulatory affairs executive with over 15 years of experience in the pharmaceutical and biotechnology industries. As the Vice President of Regulatory Affairs at Palvella Therapeutics, she is responsible for leading the company's global regulatory strategy and ensuring compliance with all applicable laws and regulations.

Experience Summary

Current Role

As the Vice President of Regulatory Affairs at Palvella Therapeutics, Christine is instrumental in guiding the company's regulatory efforts for its pipeline of innovative therapeutic products. She oversees the preparation and submission of regulatory filings, manages interactions with global health authorities, and ensures the timely and successful advancement of Palvella's product candidates through the regulatory approval process. Under her leadership, the company has achieved key regulatory milestones and strengthened its position in the market.

Career Progression

Christine's impressive career in the pharmaceutical and biotechnology industry spans over 15 years, during which she has held increasingly senior roles in regulatory affairs. Prior to joining Palvella Therapeutics, she served as the Executive Director of Global Regulatory Affairs at RemeGen Biosciences and the Executive Director of Regulatory Affairs at Marinus Pharma, where she played a pivotal role in navigating complex regulatory landscapes and securing approvals for several product candidates.

Earlier in her career, Christine held various regulatory affairs positions at Teva Pharmaceuticals, Braeburn, and Bellus Health, progressively advancing her expertise in regulatory strategy, compliance, and stakeholder management. Her deep understanding of the regulatory environment and her ability to navigate cross-functional challenges have been instrumental in driving the success of the organizations she has served.

Academic Background

Christine holds a Bachelor of Science degree in Biotechnology from the University of Pennsylvania, where she graduated with distinction. Her academic achievements and specialized knowledge in the field of biotechnology have been valuable assets in her regulatory affairs career.

Areas of Expertise

Regulatory strategy development and implementation

Global regulatory submissions and approvals

Navigating complex regulatory environments

Cross-functional collaboration and stakeholder management

Compliance with industry standards and best practices

Leadership and team-building in regulatory affairs

Professional Impact

Throughout her career, Christine has made significant contributions to the pharmaceutical and biotechnology industries. At Palvella Therapeutics, she has been instrumental in advancing the company's regulatory agenda, resulting in the successful progression of its pipeline of innovative therapies. Her expertise and strategic vision have been crucial in helping the company achieve key regulatory milestones and strengthen its competitive position in the market.

Conclusion

With her extensive experience, deep regulatory expertise, and proven track record of success, Christine Kampf is positioned as a strategic and influential leader in the pharmaceutical and biotechnology industries. Her commitment to driving regulatory excellence and her ability to navigate complex regulatory environments make her a valuable asset to Palvella Therapeutics and the broader industry.